Additionally, samples from patients with other documented IMDs, specifically, ornithine transcarbamylase deficiency, and carbamoyl phosphate synthetase I deficiency, were assessed for practical application of the method. Here, OTC is linked to hyperinsulinemic hypoglycemia, familial, 4.